Hims & Hers Health (HIMS) Change in Account Payables (2019 - 2026)

Hims & Hers Health (HIMS) reported Change in Account Payables of $167.6 million for Q1 2026, up 1058.32% on a YoY basis from $14.5 million in Q1 2025, and up 466.02% sequentially from -$45.8 million in Q4 2025.

Hims & Hers Health (HIMS) Change in Account Payables (2019 - 2026) Analysis & Trends

Hims & Hers Health (HIMS) has 8 years of Change in Account Payables data on file, last reported at $167.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Account Payables rose 1058.32% year-over-year to $167.6 million; the trailing twelve-month figure through Mar 2026 stood at $183.5 million (up 236.14% YoY), and the FY2025 full-year result was $30.3 million, down 30.69% from the prior year.
  • Change in Account Payables grew to $167.6 million in Q1 2026, from -$45.8 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $167.6 million in Q1 2026 to a low of -$45.8 million in Q4 2025.
  • A 5-year average of $15.4 million and a median of $4.0 million in 2023 frame the typical range for Change in Account Payables.
  • Across the five-year window, Change in Account Payables jumped 1922.18% in 2024 and tumbled 629.0% in 2025, its largest moves.
  • Tracing HIMS's Change in Account Payables over 5 years: stood at -$609000.0 in 2022, then jumped by 579.97% to $2.9 million in 2023, then soared by 196.2% to $8.7 million in 2024, then plunged by 629.0% to -$45.8 million in 2025, then surged by 466.02% to $167.6 million in 2026.
  • Business Quant data shows HIMS's Change in Account Payables at $167.6 million in Q1 2026, -$45.8 million in Q4 2025, and $71.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn -
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 30.60 Mn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn -
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 32.70 Mn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn -
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn -
10 Hims & Hers Health 6.44 Bn 5.69 Bn 396.79 Mn 167.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 167.64 Mn
Mar 31, 2026 167.64 Mn
Dec 31, 2025 -45.80 Mn
Dec 31, 2025 -45.80 Mn
Sep 30, 2025 70.95 Mn
Sep 30, 2025 70.95 Mn
Jun 30, 2025 -9.33 Mn
Jun 30, 2025 -9.33 Mn
Mar 31, 2025 14.47 Mn
Mar 31, 2025 14.47 Mn
Dec 31, 2024 8.66 Mn
Dec 31, 2024 8.66 Mn
Sep 30, 2024 18.90 Mn
Sep 30, 2024 18.90 Mn
Jun 30, 2024 12.55 Mn
Jun 30, 2024 12.55 Mn
Mar 31, 2024 3.60 Mn
Mar 31, 2024 3.60 Mn
Dec 31, 2023 2.92 Mn
Dec 31, 2023 2.92 Mn